Skip to main content

Fibre: what the research actually supports, and what it does not

September 11, 2026
Fibre: what the research actually supports, and what it does not

Fibre is having its moment online. "Fibermaxxing" has taken over the feeds that were talking about protein a year ago. Most of what gets shared is roughly right; some of it is not. Let's separate the two.

You do not digest fibre. Your bacteria do

Fibre is the one part of food your enzymes cannot break down. It reaches your Colon intact, where trillions of bacteria ferment it. That fermentation produces short-chain fatty acids, mainly butyrate, acetate, and propionate. Butyrate is the main fuel for the cells lining your Colon.

So the simple arrangement is: you feed the bacteria, and the bacteria provide nutrition to the gut wall.

What happens when you stop feeding them? In an experiment where mice were given human gut bacteria and then put on a low-fibre diet, the bacteria started eating the mucus layer, thinning the protective barrier.

Fibre is not one thing. It does three different jobs

Three types of fibre do three different things, and we require all of them.

Bulking fibre holds water, adds weight to stool, and speeds transit; sources include wheat bran, whole wheat roti, vegetables, and salads.

Viscous fibre forms a gel; it binds bile acids, lowers LDL cholesterol, and slows the sugar rise after a meal. Sources include oats, barley, rajma, chana, isabgol, apple, and guava.

Fermentable fibre is what your bacteria actually eat; sources include dal, onion, garlic, banana, and millets.

A mixed diet gives you all three, whereas a single supplement gives you one.

What the evidence supports

A large synthesis of 185 observational studies and 58 trials found that people eating the most fibre had roughly 15 to 30 percent lower rates of death from any cause, coronary heart disease, stroke, type 2 diabetes and Colorectal cancer than those eating the least. The benefit appeared to peak somewhere around 25 to 30 grams a day. Alongside this, the trials showed lower body weight, blood pressure and total cholesterol. The authors graded the certainty as moderate, which is honest and appropriate.

For Colorectal cancer specifically, the World Cancer Research Fund's 2018 review classifies wholegrains and fibre-containing foods as probably protective.

The finding I find most useful in clinic comes from patients who already have the disease. Among 1,575 people with stage I to III Colorectal cancer followed for a median of eight years, each additional 5 grams of daily fibre after

Patients who increased their intake after diagnosis had better survival. In the study, each 5-gram-per-day increase in fibre intake was associated with an 18 percent lower risk of Colorectal cancer-specific mortality.

What is not true

Powders are not a shortcut. Trials of fibre supplements for preventing the return of colon Polyps were negative. Supplements do have real uses. Psyllium, or isabgol, meaningfully lowers LDL cholesterol in randomised trials. But a supplement is a narrow tool, not a substitute for the diet.

Personalised fibre by microbiome is not ready. It is a real research direction. It is not clinical advice today.

What to actually do

The WHO recommends at least 25 grams of naturally occurring fibre a day for adults, from food rather than supplements. Most people fall well short of it.

Practically, that means dal or rajma or chana most days, whole grains and millets instead of refined flour, vegetables at both main meals, fruit with the skin on, and a handful of nuts or seeds.

Two cautions. Increase slowly over two to three weeks, because a sudden jump causes bloating and gas that makes most people quit. And if you have inflammatory bowel disease, a stricture, or significant irritable bowel symptoms, the right amount and type of fibre is not the same for you, so discuss it before making changes.

Sources

References

Based on peer-reviewed research and WHO/WCRF guidance.

Detect Early, Treat Right, Save Lives!

Dr. Nikhil Agrawal

About Author

Dr. Nikhil Agrawal
MS, MCh

Dr. Nikhil Agrawal is a leading GI-HPB Surgical Oncologist with 20+ years of experience in complex cancers of the esophagus, stomach, colon, rectum, liver, pancreas, gallbladder, and bile ducts. He leads the GI-HPB Oncology Program at Apollo Hospitals, Delhi and Gurugram, with expertise in advanced robotic and laparoscopic cancer surgery.

His practice focuses on evidence-based, multidisciplinary care with an emphasis on individualized treatment and long-term outcomes.

He trained at BHU, SGPGI Lucknow, AIIMS New Delhi, and SNUBH, South Korea, and is a robotic surgery proctor who trains surgeons in advanced GI-HPB cancer surgery. He is also regularly invited as faculty at national and international scientific meetings.

This website helps patients and families understand GI and HPB diseases and cancers, treatment options, and what to expect during recovery and long-term care.

Know More